Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Should low bone mass be treated?

Paul D Miller1

  • 1Colorado Center for Bone Research, Lakewood, Colorado 80227, USA.

International Journal of Fertility and Women'S Medicine
|December 13, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mineral, Bone, and Cardiovascular Disorders in CKD: The Case for a New Paradigm.

Kidney medicine·2026
Same author

Osteoporosis and CKD-Metabolic Bone Disease Under the Same Umbrella: Insights From a Joint Scientific Symposium.

Kidney international reports·2026
Same author

Treatment with romosozumab in patients with osteoporosis on maintenance hemodialysis.

Journal of bone and mineral metabolism·2026
Same author

Formation of Pyramidal Palladium Enhanced by B(C<sub>6</sub>F<sub>5</sub>)<sub>3</sub> Additive Enabling Selective Alkene Monoisomerization.

ACS omega·2026
Same author

Metal-Ligand Exchange Coupling Alters the Open-Shell Ligand Electronic Structure in a Bis(semiquinone) Complex.

Inorganic chemistry·2024
Same author

Variation from closed-shell to open shell electronic structures in oligothiophene bis(dioxolene) complexes.

Chemical science·2023
Same journal

The paradox of obstetric "near misses": converting maternal mortality into morbidity.

International journal of fertility and women's medicine·2008
Same journal

Fibroid volume, location and symptoms in women undergoing uterine artery embolization: does size or position matter?

International journal of fertility and women's medicine·2008
Same journal

Umbilical cord rupture: a case report and review of literature.

International journal of fertility and women's medicine·2008
Same journal

A continuum of care model for postpartum hemorrhage.

International journal of fertility and women's medicine·2008
Same journal

Climacteric symptom control after the addition of low-dose esterified conjugated estrogens to raloxifene standard doses.

International journal of fertility and women's medicine·2008
Same journal

Value of fetal echocardiography in diagnosis of congenital heart disease in a Serbian university hospital.

International journal of fertility and women's medicine·2008
See all related articles

Postmenopausal women with osteopenia experience more fractures than those with osteoporosis. Osteoporosis medications show promise in reducing fracture risk within the osteopenic population, aiding treatment decisions.

Area of Science:

  • Gerontology
  • Orthopedics
  • Pharmacology

Background:

  • Osteopenia is a condition characterized by low bone mass, increasing fracture risk.
  • Distinguishing fracture risk in osteopenic versus osteoporotic postmenopausal women is critical for timely intervention.
  • Current risk stratification methods require enhancement for the osteopenic demographic.

Purpose of the Study:

  • To evaluate fracture incidence in postmenopausal women with osteopenia compared to osteoporosis.
  • To explore the utility of advanced algorithms for risk stratification in osteopenic individuals.
  • To assess the efficacy of osteoporosis agents in mitigating fracture risk among osteopenic patients.

Main Methods:

  • Comparative analysis of fracture rates between osteopenic and osteoporotic postmenopausal women.

Related Experiment Videos

  • Development and validation of risk stratification algorithms.
  • Review of existing evidence on osteoporosis pharmacotherapy in osteopenic populations.

    • Main Results:

    • Higher fracture incidence observed in postmenopausal women diagnosed with osteopenia compared to those with osteoporosis.
    • Algorithms are under development to improve the identification of osteopenic individuals who would benefit from treatment.
    • Evidence supports the use of osteoporosis medications to decrease fracture risk in osteopenic women.

    Conclusions:

    • Osteopenia presents a significant fracture risk in postmenopausal women, sometimes exceeding that of osteoporosis.
    • Improved risk assessment tools are essential for guiding therapeutic decisions in osteopenia.
    • Pharmacological interventions typically used for osteoporosis are effective in reducing fractures in osteopenic individuals.